These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6889887)

  • 1. DNA crosslinking induced by 1,2-diaminocyclohexanedichloroplatinum(II) in murine leukemia L1210 cells and comparison with other platinum analogues.
    Strandberg MC; Bresnick E; Eastman A
    Biochim Biophys Acta; 1982 Aug; 698(2):128-33. PubMed ID: 6889887
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
    Gibbons GR; Kaufmann WK; Chaney SG
    Carcinogenesis; 1991 Dec; 12(12):2253-7. PubMed ID: 1747924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells.
    Di Blasi P; Bernareggi A; Beggiolin G; Piazzoni L; Menta E; Formento ML
    Anticancer Res; 1998; 18(4C):3113-7. PubMed ID: 9713519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of platinum(II) intercalating agents against murine leukemia L1210.
    McFadyen WD; Wakelin LP; Roos IA; Leopold VA
    J Med Chem; 1985 Aug; 28(8):1113-6. PubMed ID: 4020833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR
    Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DNA synthesis in different tissues of L1210-leukemia-bearing mice by new platinum (II) complexes.
    Gorneva GA; Grancharov KC; Spassovska NC
    Chemotherapy; 1993; 39(1):63-9. PubMed ID: 8444064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth, flow cytometric, and karyological characterization of L1210 cell sublines resistant to various Pt derivatives.
    Hrubisko M; Kysela B; Kuliffay P
    Neoplasma; 1989; 36(4):401-10. PubMed ID: 2770927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes.
    Eastman A; Illenye S
    Cancer Treat Rep; 1984 Sep; 68(9):1189-90. PubMed ID: 6541096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the toxicity of platinum drugs to L1210 leukaemia cells and their mutagenic properties.
    Lecointe P; Macquet JP; Butour JL
    Biochem Biophys Res Commun; 1979 Sep; 90(1):209-13. PubMed ID: 159050
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
    Mauldin SK; Husain I; Sancar A; Chaney SG
    Cancer Res; 1986 Jun; 46(6):2876-82. PubMed ID: 3698013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP).
    Hrubisko M; Ujházy V
    Neoplasma; 1990; 37(6):631-8. PubMed ID: 2274083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
    Zwelling LA; Michaels S; Schwartz H; Dobson PP; Kohn KW
    Cancer Res; 1981 Feb; 41(2):640-9. PubMed ID: 7192601
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of camphoramine chloroacetic platinum (CCP) on biomacromolecules in L1210 leukemic cells].
    Wang LG; Liu XM; Ji XJ
    Yao Xue Xue Bao; 1987 Feb; 22(2):87-92. PubMed ID: 3618241
    [No Abstract]   [Full Text] [Related]  

  • 18. Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents.
    Hacker MP; Khokhar AR; Krakoff IH; Brown DB; McCormack JJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6250-4. PubMed ID: 3779645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
    Macquet JP; Cros S; Armand JP
    Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cis-Diamminedichloroplatinum(II) (DDP)-induced crosslinking and crosslink removal in L1210 cells in vitro after theophylline co-treatment.
    Ducore JM
    Biochem Pharmacol; 1986 Feb; 35(4):607-11. PubMed ID: 3947390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.